Quote:

---

My rambling mind asked,"Who has the most to lose from LL HIV BLA and other applications" and my first thought was "Whoever makes Maraviroc", Pfizer.

---

We really should thank Pfizer for spending millions and millions of dollars on early research that proves out the benefit of CCR5 inhibitors. They spend the money we end up taking the crown.